Skip to content
Iyuda Therapeutics logo — Leading the Fight Against Cancer, Infections, and Immune Dis...

Iyuda Therapeutics

Leading the Fight Against Cancer, Infections, and Immune Disorders with Innovative Treatments

Founded 2014 Venture round Total: $1.39M Biopharma, Biotechnology +2

General Information

Company Name Iyuda Therapeutics
Founded Year 2014
Industries Biopharma, Biotechnology, Health and Wellness +1
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Iyuda Therapeutics. To contact Iyuda Therapeutics, visit iyuda.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Iyuda Therapeutics compare?

A PDF of Iyuda Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Iyuda Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Iyuda Therapeutics

Iyuda Therapeutics is a pharmaceutical therapeutics company that is leading the fight against cancer, infections, and immune disorders with innovative treatments. Founded in 2014, the company operates in the biopharma, biotechnology, health and wellness, and pharmaceutical industries. Their latest milestone is a $1.39M Venture Round investment on 14 September 2023, although the specific investors are currently undisclosed. Iyuda Therapeutics is positioning itself as a key player in addressing pressing medical challenges and has the potential to make a significant impact in the healthcare and pharmaceutical sectors.

Business keywords: pharmaceuticals, therapeutics, oncology, infectious diseases, immune disorders, cancer treatments, immunotherapy

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $1.39M -
14 Sep 2023

Iyuda Therapeutics Alternatives & Competitors

View All Alternatives
Iyuda Therapeutics vs

Developing innovative immuno-therapeutics to combat ER stress and empower the immune system in the f...

Grant
Biotechnology, Health Care
Iyuda Therapeutics vs

Our vision is to harness the power of the immune system to develop novel therapies against cancer &...

IPO
5202 employees
Biopharma, Biotechnology
Iyuda Therapeutics vs
Immunaeon
Immunaeon United States

Connecting Today's Science to Tomorrow's Cures

5 employees
Biopharma, Biotechnology

FAQ About Iyuda Therapeutics

Leading the Fight Against Cancer, Infections, and Immune Disorders with Innovative Treatments
Iyuda Therapeutics was founded in 2014.
Iyuda Therapeutics operates in Biopharma, Biotechnology, Health and Wellness and Pharmaceutical. Its work centres on pharmaceuticals, therapeutics, oncology and infectious diseases.
Iyuda Therapeutics has completed 1 funding round, raising a total of $1.39M. The latest funding stage is Venture round.
Top alternatives and competitors to Iyuda Therapeutics include Quentis Therapeutics, BioNTech SE, Immunaeon, Immunophage Biotech, Asylia Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Iyuda Therapeutics and Quentis Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Iyuda Therapeutics, https://bouncewatch.com/company/iyuda-therapeutics, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout